Next Article in Journal
Current High-Throughput Approaches of Screening Modulatory Effects of Xenobiotics on Cytochrome P450 (CYP) Enzymes
Next Article in Special Issue
Development and Assessment of a Diagnostic DNA Oligonucleotide Microarray for Detection and Typing of Meningitis-Associated Bacterial Species
Previous Article in Journal
Obesity Proteomics: An Update on the Strategies and Tools Employed in the Study of Human Obesity
Previous Article in Special Issue
A Parallel Software Pipeline for DMET Microarray Genotyping Data Analysis
Article Menu
Issue 3 (September) cover image

Export Article

Open AccessReview
High-Throughput 2018, 7(3), 28;

The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders

Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta Campus, 88100 Catanzaro, Italy
Department of Medical and Surgical Sciences, Pediatric Unit, Magna Graecia University, 88100 Catanzaro, Italy
Author to whom correspondence should be addressed.
Received: 30 July 2018 / Revised: 6 September 2018 / Accepted: 6 September 2018 / Published: 14 September 2018
(This article belongs to the Special Issue Applications of Microarrays in Diagnostics)
Full-Text   |   PDF [2351 KB, uploaded 14 September 2018]   |  


Submicroscopic chromosomal copy number variations (CNVs), such as deletions and duplications, account for about 15–20% of patients affected with developmental delay, intellectual disability, multiple congenital anomalies, and autism spectrum disorder. Most of CNVs are de novo or inherited rearrangements with clinical relevance, but there are also rare inherited imbalances with unknown significance that make difficult the clinical management and genetic counselling. Chromosomal microarrays analysis (CMA) are recognized as the first-line test for CNV detection and are now routinely used in the clinical diagnostic laboratory. The recent use of CMA platforms that combine classic copy number analysis with single-nucleotide polymorphism (SNP) genotyping has increased the diagnostic yields. Here we discuss the application of the Cytoscan high-density (HD) SNP-array for the detection of CNVs. We provide an overview of molecular analyses involved in identifying pathogenic CNVs and highlight important guidelines to establish pathogenicity of CNV. View Full-Text
Keywords: copy number variations; SNP-array; neurodevelopmental disorders copy number variations; SNP-array; neurodevelopmental disorders

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Scionti, F.; Di Martino, M.T.; Pensabene, L.; Bruni, V.; Concolino, D. The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders. High-Throughput 2018, 7, 28.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
High-Throughput EISSN 2571-5135 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top